Progress in medicinal chemistry. Volume 44 /
The perceived lack of drug discovery productivity in recent times has led to much debate in the pharmaceutical/biotechnology industry as escalating R & D costs are not being matched by increased output. Few observers doubt that selecting the right targets, ie those which are critical to disease...
| Άλλοι συγγραφείς: | , |
|---|---|
| Μορφή: | Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Amsterdam ; Boston :
Elsevier,
2006.
|
| Σειρά: | Progress in Medicinal Chemistry ;
v. 44. |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
